So, osimertinib is a kind of inhibitor. It’s used for treating NSCLC, you know? And it focuses on EGFR mutations, especially the T790M one. It comes in tablet form, with two sizes—40 mg and 80 mg, just like in a movie.
They usually say you take 80 mg every day. You can take it with or without eating, it’s cool. The tablets come in bottles, and each bottle has 30 tabs.
So, this osimertinib stuff is like a second line of defense against tumors with the EGFR T790M mutation. It kicks in if the first EGFR inhibitor treatment doesn’t work. The size and how these tablets are made are super important for patients to take them right and make them work well.
